Quest Diagnostics Inc (DGX) stock
DGXNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 23, 2026Score 12/308% above fair value
$256.35−5.86 (-2.23%)
Close on Nov 17, 2026Market cap $28.20BP/E 25.6Yield –
Quest Diagnostics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Quest Diagnostics's operating cash flow for the twelve months ending Sep 30, 2026 was $1.95B, up 3.5% year over year. For fiscal 2025 it was $1.89B, up 41.4% from the year before. Over ten years it grew 8.7% a year on average. The highest annual figure on record is $2.23B in fiscal 2021.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.89B | +41.4% |
| FY2024 | Dec 31, 2024 | $1.33B | +4.9% |
| FY2023 | Dec 31, 2023 | $1.27B | -26.0% |
| FY2022 | Dec 31, 2022 | $1.72B | -23.1% |
| FY2021 | Dec 31, 2021 | $2.23B | +11.4% |
| FY2020 | Dec 31, 2020 | $2.01B | +61.3% |
| FY2019 | Dec 31, 2019 | $1.24B | +3.6% |
| FY2018 | Dec 31, 2018 | $1.20B | +2.1% |
| FY2017 | Dec 31, 2017 | $1.18B | +5.3% |
| FY2016 | Dec 31, 2016 | $1.12B | +35.9% |
| FY2015 | Dec 31, 2015 | $821.00M | -13.0% |
| FY2014 | Dec 31, 2014 | $944.00M | +44.8% |
| FY2013 | Dec 31, 2013 | $652.00M | -45.1% |
| FY2012 | Dec 31, 2012 | $1.19B | +32.6% |
| FY2011 | Dec 31, 2011 | $895.00M | -19.9% |
| FY2010 | Dec 31, 2010 | $1.12B | +12.1% |
| FY2009 | Dec 31, 2009 | $997.42M | -6.2% |
| FY2008 | Dec 31, 2008 | $1.06B | +14.7% |
| FY2007 | Dec 31, 2007 | $926.92M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $611.00M | +8.5% |
| Q2 FY2026 | Jun 30, 2026 | $597.00M | +9.7% |
| Q1 FY2026 | Mar 31, 2026 | $278.00M | -11.5% |
| Q4 FY2025 | Dec 31, 2025 | $465.00M | +0.2% |
| Q3 FY2025 | Sep 30, 2025 | $563.00M | +58.1% |
| Q2 FY2025 | Jun 30, 2025 | $544.00M | +51.1% |
| Q1 FY2025 | Mar 31, 2025 | $314.00M | +103.9% |
| Q4 FY2024 | Dec 31, 2024 | $464.00M | -12.0% |
| Q3 FY2024 | Sep 30, 2024 | $356.00M | +72.0% |
| Q2 FY2024 | Jun 30, 2024 | $360.00M | -18.9% |
| Q1 FY2024 | Mar 31, 2024 | $154.00M | +63.8% |
| Q4 FY2023 | Dec 31, 2023 | $527.00M | +57.8% |
| Q3 FY2023 | Sep 30, 2023 | $207.00M | -58.8% |
| Q2 FY2023 | Jun 30, 2023 | $444.00M | +10.4% |
| Q1 FY2023 | Mar 31, 2023 | $94.00M | -80.4% |
| Q4 FY2022 | Dec 31, 2022 | $334.00M | -30.6% |
| Q3 FY2022 | Sep 30, 2022 | $502.00M | -10.5% |
| Q2 FY2022 | Jun 30, 2022 | $402.00M | -12.6% |
| Q1 FY2022 | Mar 31, 2022 | $480.00M | -34.3% |
| Q4 FY2021 | Dec 31, 2021 | $481.00M | -11.1% |
| Q3 FY2021 | Sep 30, 2021 | $561.00M | -34.9% |
| Q2 FY2021 | Jun 30, 2021 | $460.00M | +29.6% |
| Q1 FY2021 | Mar 31, 2021 | $731.00M | +196.0% |
| Q4 FY2020 | Dec 31, 2020 | $541.00M | +55.5% |
| Q3 FY2020 | Sep 30, 2020 | $862.00M | +188.3% |
| Q2 FY2020 | Jun 30, 2020 | $355.00M | +10.6% |
| Q1 FY2020 | Mar 31, 2020 | $247.00M | -10.2% |
| Q4 FY2019 | Dec 31, 2019 | $348.00M | +18.0% |
| Q3 FY2019 | Sep 30, 2019 | $299.00M | -25.6% |
| Q2 FY2019 | Jun 30, 2019 | $321.00M | -0.6% |
| Q1 FY2019 | Mar 31, 2019 | $275.00M | +52.8% |
| Q4 FY2018 | Dec 31, 2018 | $295.00M | -8.7% |
| Q3 FY2018 | Sep 30, 2018 | $402.00M | +11.0% |
| Q2 FY2018 | Jun 30, 2018 | $323.00M | +9.9% |
| Q1 FY2018 | Mar 31, 2018 | $180.00M | -8.2% |
| Q4 FY2017 | Dec 31, 2017 | $323.00M | -8.0% |
| Q3 FY2017 | Sep 30, 2017 | $362.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $294.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $196.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $351.00M | – |
See a number that looks wrong?